Sanyaolu Leigh N, Hayes Catherine V, Lecky Donna M, Ahmed Haroon, Cannings-John Rebecca, Weightman Alison, Edwards Adrian, Wood Fiona
Division of Population Medicine, Cardiff University, Cardiff CF14 4YS, UK.
Primary Care and Interventions Unit, UK Health Security Agency (UKHSA), Gloucester GL1 1DQ, UK.
Antibiotics (Basel). 2023 Feb 22;12(3):434. doi: 10.3390/antibiotics12030434.
Urinary tract infections (UTIs) are a common and significant problem for patients, clinicians, and healthcare services. Recurrent UTIs (rUTIs) are common, with a 3% prevalence in the UK. Although acute UTIs have a significant negative impact on the lives of patients, evidence of the impact of rUTIs is limited. To enhance shared decision-making around rUTI management, it is important to understand both the patients' and healthcare professionals' (HCPs') perspectives. The objective of this qualitative evidence synthesis is to understand patients' and HCPs' experiences and views in the management of rUTIs.
A qualitative evidence synthesis (QES) was performed that included primary qualitative studies involving patients with rUTIs or primary care HCPs who manage patients with rUTIs, up to June 2022. The following databases were searched: MEDLINE, Embase, CINAHL, PsycInfo, ASSIA, Web of Science, Cochrane Database of Systematic Reviews, Epistemonikos, Cochrane Central Registry of Controlled Trials, OpenGrey, and the Health Management Information Consortium (HMIC). The QES was prospectively registered on PROSPERO (CRD42022295662). Reciprocal translation was conducted and developed into a line of argument synthesis. We appraised the confidence in our review findings by using GRADE-CERQual.
Twelve studies were included in the final review; ten of those included patients, and three included HCPs (one study included both). Our review demonstrates that women with rUTIs have a unique experience, but it is generally of a chronic condition with significant impacts on numerous aspects of their lives. Antibiotics can be "transformative", but patients have serious concerns about their use and feel non-antibiotic options need further research and discussion. HCPs share similar views about the impacts of rUTIs and concerns about antibiotic use and find the management of rUTIs to be complex and challenging. Based on our GRADE-CERQual assessment of the review findings, we have moderate confidence in those related to patients and low confidence in those related to HCPs. New conceptual models for both patients and HCPs are presented.
This review has significant clinical implications. Patients require information on antibiotic alternative acute and preventative treatments for rUTIs, and this is not currently being addressed. There are communication gaps around the impact of rUTIs on patients, their perceived expectation for antibiotics, and the reasons for treatment failure. Further development of current clinical guidance and a patient decision aid would help address these issues.
尿路感染(UTIs)对于患者、临床医生和医疗服务来说是一个常见且严重的问题。复发性尿路感染(rUTIs)很常见,在英国的患病率为3%。虽然急性UTIs对患者的生活有重大负面影响,但rUTIs影响的证据有限。为了加强围绕rUTI管理的共同决策,了解患者和医疗保健专业人员(HCPs)的观点都很重要。这项定性证据综合分析的目的是了解患者和HCPs在rUTIs管理方面的经历和观点。
进行了一项定性证据综合分析(QES),纳入了截至2022年6月涉及rUTIs患者或管理rUTIs患者的初级保健HCPs的初级定性研究。检索了以下数据库:MEDLINE、Embase、CINAHL、PsycInfo、ASSIA、科学网、Cochrane系统评价数据库、Epistemonikos、Cochrane对照试验中央注册库、OpenGrey和健康管理信息联盟(HMIC)。该QES已在PROSPERO(CRD42022295662)上进行了前瞻性注册。进行了双向翻译并发展为一系列论证综合分析。我们使用GRADE-CERQual评估了对我们综述结果的信心。
最终综述纳入了12项研究;其中10项纳入了患者,3项纳入了HCPs(1项研究同时纳入了两者)。我们的综述表明,患有rUTIs的女性有独特的经历,但总体上是一种慢性病,对她们生活的许多方面有重大影响。抗生素可能具有“变革性”,但患者对其使用存在严重担忧,并认为非抗生素选择需要进一步研究和讨论。HCPs对rUTIs的影响以及对抗生素使用的担忧有类似看法,并发现rUTIs的管理复杂且具有挑战性。根据我们对综述结果的GRADE-CERQual评估,我们对与患者相关的结果有中等信心,对与HCPs相关的结果信心较低。提出了针对患者和HCPs的新概念模型。
本综述具有重要的临床意义。患者需要有关rUTIs抗生素替代急性和预防性治疗的信息,而目前这一需求尚未得到满足。在rUTIs对患者的影响、他们对抗生素的预期以及治疗失败的原因方面存在沟通差距。进一步完善当前的临床指南和患者决策辅助工具将有助于解决这些问题。